Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness

B Glampson, J Brittain, Amit Kaura, A Mulla, L Mercuri, S Brett, P Aylin, T Sandall, I Goodman, J Redhead, K Saravanakumar, View ORCID ProfileE K Mayer
doi: https://doi.org/10.1101/2021.04.08.21254580
B Glampson
1ICT, Imperial College Healthcare NHS Trust, Praed Street, W2 1NY, London, UK
Roles: Research Informatics Programme Manager Department of Surgery & Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Brittain
2Imperial College London, 10th Floor QEQM building, St Mary’s Hospital Campus Praed Street, W2 1NY, London, UK
Roles: Clinical Research Fellow NIHR Imperial Biomedical Research Centre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Kaura
3Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, W12 0HS, London, UK
Roles: NIHR academic clinical fellow ICT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Mulla
4Imperial College Healthcare NHS Trust, Praed Street, W2 1NY, London, UK
Roles: Deputy Data Warehouse Manager ICT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Mercuri
4Imperial College Healthcare NHS Trust, Praed Street, W2 1NY, London, UK
Roles: Deputy Data Warehouse Manager Department of Surgery & Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Brett
5Imperial College London, Hammersmith Hospital, W12 0HS, London, UK
Roles: Professor of Critical Care School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Aylin
6Imperial College London, Medical School Building, St Mary’s Hospital, W2 1PG, London, UK
Roles: Professor of Epidemiology and Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Sandall
7North West London Collaboration of Clinical Commissioning Groups, 15 Marylebone Road, NW1 5JD, London, UK
Roles: Acting Director of Commissioning Hillingdon Clinical Commis0073ioning Group
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Goodman
8Boundary House, Cricket Field Rd, Uxbridge, UB8 1QG, UK
Roles: Chair Hillingdon CCG Medical Director’s Office
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Redhead
4Imperial College Healthcare NHS Trust, Praed Street, W2 1NY, London, UK
Roles: Medical Director North West London Collaboration of Clinical Commissioning Groups
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Saravanakumar
915 Marylebone Road, NW1 5JD, London, UK
Roles: Associate Director of Business Intelligence Department of Surgery & Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E K Mayer
2Imperial College London, 10th Floor QEQM building, St Mary’s Hospital Campus Praed Street, W2 1NY, London, UK
Roles: Clinical Senior Lecturer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E K Mayer
  • For correspondence: e.mayer@imperial.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To assess the early vaccine administration coverage and vaccine effectiveness and outcome data across an integrated care system of eight CCGs leveraging a unique population-level care dataset

Design Retrospective cohort study.

Setting Individuals eligible for COVID 19 vaccination in North West London based on linked primary and secondary care data.

Participants 2,183,939 individuals eligible for COVID 19 vaccination

Results During the NWL vaccine programme study time period 5.88% of individuals declined and did not receive a vaccination. Black or black British individuals had the highest rate of declining a vaccine at 16.14% (4,337). There was a strong negative association between deprivation and rate of declining vaccination (r=-0.94, p<0.01) with 13.5% of individuals declining vaccination in the most deprived postcodes compared to 0.98% in the least deprived postcodes.

In the first six days after vaccination 344 of 389587 individuals tested positive for COVID-19 (0.09%). The rate increased to 0.13% (525/389,243) between days 7 and 13, before then gradually falling week on week.

At 28 days post vaccination there was a 74% (HR 0.26 (0.19-0.35)) and 78% (HR 0.22 (0.18-0.27)) reduction in risk of testing positive for COVID-19 for individuals that received the Oxford/Astrazeneca and Pfizer/BioNTech vaccines respectively, when compared with unvaccinated individuals.

After vaccination very low rates of hospital admission were seen in individuals testing positive for COVID-19 (0.01% of all patients vaccinated).

Conclusions This study provides further evidence that a single dose of either the Pfizer/BioNTech vaccine or the Oxford/Astrazeneca vaccine is effective at reducing the risk of testing positive for COVID-19 up to 60 days across all adult age groups, ethnic groups, and risk categories in an urban UK population. There was no difference in effectiveness up to 28 days between the Oxford/Astrazeneca and Pfizer/BioNtech vaccines.

In those declining vaccination higher rates were seen in those living in the most deprived areas and in Black and Black British groups.

There was no definitive evidence to suggest COVID-19 was transmitted as a result of vaccination hubs during vaccine the administration roll-out in NWL, and the risk of contracting COVID-19 and/or becoming hospitalised after vaccination has been demonstrated to be very low in the vaccinated population.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was enabled by the Imperial Clinical Analytics Research and Evaluation (iCARE) environment and Whole Systems Integrated Care and used the iCARE & WSIC team and data resources (https://imperialbrc.nihr.ac.uk/facilities/icare/). The research was supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC), the National Institute of Health Research (NIHR) Imperial Patient Safety Translational Research Centre and the NW London NIHR Applied Research Collaboration. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was undertaken within a Research Database that was given favourable Ethics approval by the West Midlands - Solihull Research Ethics Committee. REC reference: 18/WM/0323. IRAS project ID: 252449.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data sharing

We are unable to extract or publish patient level data from iCARE and Whole systems integrated care due to data protection restrictions. Any request to access data can be made to Nwlccgs.covid19IG{at}nhs.net referring to the title of this paper.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 10, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness
B Glampson, J Brittain, Amit Kaura, A Mulla, L Mercuri, S Brett, P Aylin, T Sandall, I Goodman, J Redhead, K Saravanakumar, E K Mayer
medRxiv 2021.04.08.21254580; doi: https://doi.org/10.1101/2021.04.08.21254580
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness
B Glampson, J Brittain, Amit Kaura, A Mulla, L Mercuri, S Brett, P Aylin, T Sandall, I Goodman, J Redhead, K Saravanakumar, E K Mayer
medRxiv 2021.04.08.21254580; doi: https://doi.org/10.1101/2021.04.08.21254580

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)